For those considering the rapidly advancing CAR-T therapy, here is a quick summary of a small cohort study which used steroids in combination with CAR-T to mitigate the potentially fatal cytokine release syndrome (CRS) and neurotoxicity in CAR-T patients. Grade 3, 4 and 5 CRS were not oberseved and far fewer patients required intensive care in the study.